FDA greenlights Neuroelectrics to help patients with Major Depression at home amidst Covid-19 restrictions
The FDA has given the green light to our at-home Depression therapy during COVID-19, offering personalized brain stimulation
The FDA has given the green light to our at-home Depression therapy during COVID-19, offering personalized brain stimulation
At Neuroelectrics, we believe in the advantages and effectiveness of transcranial electric stimulation (tES) in treating numerous brain diseases. Yet, despite the increasing number of tES publications per year, the lion’s share in the market of non-invasive brain stimulation technologies…
One of the emerging trends in the field of tDCS for medical applications is telemedicine or home use. The main reasons for the field’s growth are that we know this to be a safe technique, with only minor side effects…
At the recent American Epilepsy Society Annual Meeting in New Orleans, Neuroelectrics Corporation presented positive results from its clinical trial treating patients with drug resistant epilepsy with Starstim a device that uses mild electric currents applied on the scalp to calm abnormal activity of…